Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease

Frontiers in Genetics

Volumn 3, Issue OCT, 2012, Pages

  Young, R P ^a   Hopkins, R J ^a   Gamble, G D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

COPD; Genetic susceptibility; Lung cancer; Risk prediction; Screening

Indexed keywords

EID: 84876105712     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2012.00210     Document Type: Article

References (69)

1. Alberg, A. J., and Samet, J. M. (2003). Epidemiology of lung cancer. Chest 123,21-49.
2. Amos, C. I., Wu, X., Broderick, P., Gorlov, I. P., Gu, J., Eisen, T., et al. (2008). Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 40, 616-622.
3. Anthonisen, N. R., Skeans, M. A., Wise, R. A., Manfreda, J., Kanner, R. E., and Connett, J. E. (2005). The effects of smoking cessation intervention on 14.5 year mortality: a randomized clinical trial. Ann. Intern. Med. 142, 233-239.
4. Bach, P. B., Katten, M. W., Thornquist, M. D., Kris, M. G., Tate, R. C, Barnett, M. J., et al. (2003). Variation in lung cancer risk among smokers.J. Natl. Cancer Inst. 95,470-478.
5. Bach, P. B., Mirkin, J. N., Oliver, T. K., Azzoli, C. G., Berry, D. A., Brawley, O. W., et al. (2012). Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307, 2418-2429.
6. Broderick, P., Wang, Y., Vijayakarishnan, V., Matakidou, A., Spitz, M. R., Eisen, T., et al. (2009). Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res. 69, 6633-6641.
7. Burrows, B., Knudson, R. J., Cline, M. G., and Lebowitz, M. D. (1977). Qualitative relationships between cigarette smoking and ventilatory function. Am. Rev. Respir. Dis. 115, 195-205.
8. Caramori, G., Casolari, P., Cavallesco, G. N., Giuffre, S., Adcock, I., Papi, A., et al. (2010). Mechanisms involved in lung cancer development in COPD. Int.. Biochem. Cell Biol. 43, 1030-1044.
9. Cassidy, A., Myles, J. P., Liloglou, T., Duffy, S. W, and Field, J. K. (2006). Defining high risk individuals in a population-based molecular epidemiological study of lung cancer. Int.J. Oncol. 28,1295-1301.
10. Castaldi, P. J., Cho, M. H., Cohn, M., Langerman, F., Moran, S., Tarragona, N., et al. (2009). The COPD genetic association compendium: a comprehensive online data base of COPD genetic associations. Hum. Mol. Genet. 19, 526-534.
11. Castaldi, P. J., Demeo, D. L., Hersh, C. P., Lomas, D. A., Soerheim, I. C, Gulsvik, A., et al. (2011). Impact of non-linear smoking effects on the identification of gene by smoking interactions in COPD genetics studies. Thorax 66, 903-909.
12. Chen, Y. (1999). Genetic epidemiology of pulmonary function. Thorax 54, 818-824.
13. de Andrade, M., Li, Y., Marks, R. S., Deschamps, C, Scanlon, P. D., Olswold, C. L., et al. (2011). Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer. Cancer Prev. Res. 5, 365-373.
14. de Torres, J., Bastarrika, G., Wisnivesky, J. P., Alcaide, A. B., Campo, A., Seijo, L. M., et al. (2007). Assessing the relationship between lung cancer risk and emphysema detected on low dose CT of the chest. Chest 132, 1932-1938.
15. El Zein, R. A., Young, R. P., Hopkins, R. J., and Etzel, C. J. (2012). Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer: important considerations when evaluating risk. Cancer Prev. Res. 5, 522-527.
16. Hill, K., Goldstein, R. S., Guyatt, G. H., Blouin, M., Tan, W. C, Davis, L. L., et al. (2010). Prevalence and under-diagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ 182, 673-678.
17. Hopkins, R. J., Young, R. P., Hay, B., and Gamble, G. D. (2011). Gene-based lung cancer risk score triggers smoking cessation in randomly recruited smokers. Am. J. Respir. Crit. Med. 183, A5441.
18. Hopkins, R. J., Young, R. P., Hay, B., and Gamble, G. D. (2012). Lung cancer risk testing enhances NRT uptake and quit rates in randomly recruited smokers offered a gene-based risk test. Am. J. Respir. Crit. Care Med. 185.A2590.
19. Houghton, A. M., Mouded, M., and Shapiro, S. D. (2008). Common origins of lung cancer and COPD. Nat. Med. 14, 1023-1024.
20. Hung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., et al. (2008). A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452, 633-637.
21. Jaklitsch, M. T., Jacobson, F. L., Austin, J. H. M., Field, J. K., Jett, J. R., Keshavjee, S., et al. (2012). The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.J. Thorac. Cardiovasc. Surg. 144, 33-38.
22. Jonsson, S., Thorsteinsdottir, U., Gudbjartsson, D. E, Jonsson, H. H., Kristjansson, K., Arnason, S., et al. (2004). Familial risk of lung carcinoma in the Icelandic population. JAMA 292, 2977-2983.
23. Kohansal, R., Martinez-Camblor, P., Agusti, A., Buist, A. S., Mannino, D. M., and Soriano, J. B. (2009). The natural history of chronic airflow obstruction revisited: an analysis of the Framingham Offspring Cohort. Am. I Respir. Crit. Care Med. 180, 3-10.
24. Lambrechts, D., Buysschaert, I., Zanen, P., Coolen, J., Lays, N., Cuppens, H., et al. (2010). The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema. Am. J. Respir. Crit. Care Med. 181, 486-493.
25. Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., et al. (2000). Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark and Finland. N. Eng. J. Med. 343, 78-85.
26. L0kke, A., Lange, P., Scharling, H., Fabricius, P., and Vestbo, J. (2006). Developing COPD: a 25 year follow up study of the general population. Thorax 61, 935-939.
27. Mannino, D. M., Watt, G., Hole, D., Gillis, C, Hart, C, McConnachie, A., et al. (2006). The natural history of chronic obstructive pulmonary disease. Eur. Respir. J. 27, 627-643.
28. McBride, C. M, Bepler, G., Lipkus, I. M., Lyna, P., Samsa, G., Albright, J., et al. (2002). Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol. Biomarkers Prev. 11,521-528.
29. Mohamed Hoesein, E A. A., de Hoop, B., Zanen, P., Gietema, H., Kruitwagen, C. L., van Ginneken, B., et al. (2011). CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax 66, 782-787.
30. Molfino, N. A. (2004). Genetics of COPD. Chest 125, 1929-1940.
31. National Lung Screening Trial Research Team. (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Eng. J. Med. 365, 395-409.
32. Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E., and Doll, R. (2000). Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. Br. Med.J. 321,323-329.
33. Pillai, S. G., Ge, D., Zhu, G., Kong, X., Shianna, K. V., Need, A. C, et al. (2009). A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 5, el000421. doi: 10.1371/journal.pgen.l000421
34. Sekine, Y, Katsura, H., Koh, E., Hiroshima, K., and Fujisawa, T. (2012). Early detection of COPD is important for lung cancer surveillance. Eur. Respir.J. 39, 1230-1240.
35. Silverman, E. K., Vestbo, J., Agusti, A., Anderson, W., Bakke, P. S., Barnes, K. C, et al. (2011). Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report. COPD 8, 121-35.
36. Smerecnik, C, Grispen, J. E., and Quaak, M. (2012). Effectiveness of testing for genetic susceptibility to smoking-related diseases on smoking cessation outcomes: a systematic review and meta-analysis. Tob. Control 21, 347-354
37. Spitz, M. R., Amos, C. I., D'Amellio, A. Jr., Dong, Q., and Etzel, C. (2009).Re: discriminatory accuracy from single-nucleotide polymorphisms in models.J. Natl. Cancer Inst. 24, 1731-1732.
38. Spitz, M. R., Hong, W. K., Amos, C. I., Wu, X., Schabath, M. B., Dong, Q., et al. (2007). A risk model for prediction of lung cancer.J. Natl. Cancer. Inst. 99, 715-726.
39. Tammemagi, C. M., Pinsky, P. F., Caporaso, N. E., Kvale, P. A., Hocking, W. G., Church, T. R., et al. (2011). Lung cancer risk prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial models and validation.J. Natl. Cancer Inst. 103, 1058-1068.
40. Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., et al. (2008). A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452, 638-642.
41. Valdez, R., Yoon, P. W., Qureshi, N, Green, R. E, and Khoury, M. J. (2010). Family history in public health practice: a genomic tool for disease prevention and health promotion. Ann. Rev. Public Health 31, 69-87.
42. Walser, T., Cui, X., Yanagawa, J., Lee, J. M., Heinrich, E., Lee, G., et al. (2008). Smoking and lung cancer: the role of inflammation. Proc. Am. Thorac. Soc. 5,811-815.
43. Weinstein, N. D., Marcus, S. E., and Moser, R. P. (2005). Smokers' unrealistic optimism about their risk. Tob. Control 14, 55-59.
44. Wilk, J. B., Chen, T., Gottlieb, D. J., Walter, R. E., Nagle, M. W., Brandler, B. J., et al. (2009). A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet. 5, el000429. doi: 10.1371/journal.pgen.l000429
45. Wilson, D. O., Weissfeld, J. L, Balkan, A., Schragin, J. G., Fuhrman, C. R., Fisher, S. N., et al. (2008). Association of radiographic emphysema and airflow obstruction with lung cancer. Am. J. Respir. Crit. Care Med. 178, 738-744.
46. Witschi, H. (2001). A short history of lung cancer. Toxicol. Sci. 64,4-6.
47. Woloshin, S., Schwartz, L. M., and Welch, H. G. (2008). The risk of death by age, sex, and smoking status in the United States: putting health risks in context.J. Natl. Cancer Inst. 100, 845-853.
48. Yang, I. A., Relan, V., Wright, C. M., Davidson, M. R., Sriram, K. B., Savarimuthu Francis, S. M., et al. (2011). Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin. Ther. Targets 15, 439-456.
49. Young, R. P., Hopkins, R., and Eaton, T. E. (2007). FEV1: not just a lung function test but a marker of premature death from all causes. Eur. Respir. J. 30,616-622.
50. Young, R. P., Hopkins, R., and Eaton, T. E. (2009a). Pharmacological actions of statins: potential utility in COPD. Eur. Respir. Rev. 18, 222-232.
51. Young, R. P., Hopkins, R. J., Christmas, T., Black, P. N., Metcalf, P., and Gamble, G. D. (2009b). COPD prevalence is increased in lung cancer independence of age, gender and smoking history. Eur. Respir. J. 34, 380-386.
52. Young, R. P., Hopkins, R. J., Hay, B. A., Epton, M. J., Mills, G. D., Black, P. N., et al. (2009c). A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers. Postgrad. Med. J. 85, 515-524.
53. Young, R. P., Hopkins, R. J., Hay, B. A., Epton, M. J., Mills, G. D., Black, P. N., et al. (2009d). Lung cancer susceptibility model based on age, family history and genetic variants. PLoS ONE 4, e5302. doi: 10.1371/journal.pone.0005302
54. Young, R. P., and Hopkins, R. J. (2011). COPD and lung cancer linked at a molecular genetic level. Chest 140, 266-267.
55. Young, R. P., and Hopkins, R. J. (2011b). How the genetics of lung cancer may overlap with COPD. Respirology 16, 1047-1055.
56. Young, R. P., and Hopkins, R. J. (2011c). The genetics of lung cancer susceptibility and COPD. Lancet Oncol. 12, 622-623.
57. Young, R. P., and Hopkins, R. J. (20 lid). GWAS in lung disease. Thorax 66, 1012-1013.
58. Young, R. P., and Hopkins, R. J. (2012a). Lung cancer risk prediction to select smokers for CT screening. Cancer Prev. Res. 5, 697-698.
59. Young, R. P., and Hopkins, R. J. (2012b). Diagnosing COPD and targeting lung cancer screening. Eur. Respir. J. 40, 1063-1064.
60. Young, R. P., and Hopkins, R. J. (2012c). Increasing smokers' risk perception improves CT screening participation. Thorax 67, 834-835.
61. Young, R. P., Hopkins, R. J., Gamble, G. D., Etzel, C, El-Zein, R., and Crapo, J. D. (2011a). Genetic evidence linking lung cancer and COPD: a new perspective. Appl. Clin. Genet. 4, 1-13.
62. Young, R. P., Hopkins, R. J., Hay, B. A., and Gamble, G. D. (2011b). GSTM1 null genotype in COPD and lung cancer: evidence of amodifier or confounding effect? Appl. Clin. Genet. 1, 137-144.
63. Young, R. P., Hopkins, R. J., Hay, B. A., Whittington, C. E, Epton, M. J., and Gamble, G. D. (2011c). FAM13A locus in COPD indepen-dently associated with lung cancer-evidence of a molecular genetic link between COPD and lung cancer. Appl. Clin. Genet. 4, 1-10.
64. Young, R. P., Hopkins, R. J., Whittington, C. E, Hay, B. A., Epton, M. J., and Gamble, G. D. (2011d). Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after genotyping for COPD. PLoS ONE 6, el6476. doi: 10.1371/joumal.pone.0016476
65. Young, R. P., Hopkins, R. J., Hay, B. A., and Gamble, G. D. (2012a). Joint effect of single-nucleotide polymorphisms and smoking exposure in chronic obstructive pulmonary disease risk. Am. J. Respir. Crit. CareMed. 185, 683; author reply 683-684.
66. Young, R. P., Hopkins, R. J., and Midthun, D. E. (2012b). Benefits and harms of CT screening for lung cancer: a systematic re view-letter. JAMA 308, 1320-1321.
67. Young, R. P., Hopkins, R. J., Hay, B. A., Epton, M. J., Black, P. N., and Gamble, G. D. (2008). Lung cancer gene associated with COPD: triple whammy or possible confounding effect? Eur. Respir. J. 32, 1158-1164.
68. Young, R. P., Hopkins, R. J., Smith, M., and Hogarth, D. K. (2010a). Smoking cessation: the potential role of risk assessment tools as motivational triggers. Postgrad.Med.J. 86, 26-33.
69. Young, R. P., Whittington, C. E, Hopkins, R. J., Hay, B. A., Epton, M. J., and Black, P. N. (2010b). Chromosome 4q31 locus in COPD also associated with lung cancer. Eur. Respir. J. 36, 1375-1382.